[1]
Rebersek, M. et al. 2011. Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis. Radiology and Oncology. 45, 4 (Dec. 2011).